Report: Spinifex Pharmaceuticals deal could hit $700M

By Westfair Online

No Comment

Swiss giant Novartis is acquiring Stamford-based Spinifex Pharmaceuticals, a 20-person startup, in a deal worth as much as $700 million.

This content is for Westfair Online members only. Please login to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.


About the author